Evidence Synthesis and Decision Modeling, PRECISIONheor, Vancouver, BC, Canada.
Evidence Synthesis and Decision Modeling, PRECISIONheor, Vancouver, BC, Canada.
Value Health. 2023 Apr;26(4):465-476. doi: 10.1016/j.jval.2022.11.017. Epub 2022 Dec 9.
Network meta-analysis (NMA) of time-to-event outcomes based on constant hazard ratios can result in biased findings when the proportional hazards (PHs) assumption does not hold in a subset of trials. We aimed to summarize the published non-PH NMA methods for time-to-event outcomes, demonstrate their application, and compare their results.
The following non-PH NMA methods were compared through an illustrative case study in oncology of 4 randomized controlled trials in terms of progression-free survival and overall survival: (1) 1-step or (2) 2-step multivariate NMAs based on traditional survival distributions or fractional polynomials, (3) NMAs with restricted cubic splines for baseline hazard, and (4) restricted mean survival NMA.
For progression-free survival, the PH assumption did not hold across trials and non-PH NMA methods better reflected the relative treatment effects over time. The most flexible models (fractional polynomials and restricted cubic splines) fit better to the data than the other approaches. Estimated hazard ratios obtained with different non-PH NMA methods were similar at 5 years of follow-up but differed thereafter in the extrapolations. Although there was no strong evidence of PH violation for overall survival, non-PH NMA methods captured this uncertainty in the relative treatment effects over time.
When the PH assumption is questionable in a subset of the randomized controlled trials, we recommend assessing alternative non-PH NMA methods to estimate relative treatment effects for time-to-event outcomes. We propose a transparent and explicit stepwise model selection process considering model fit, external constraints, and clinical validity. Given inherent uncertainty, sensitivity analyses are suggested.
当部分试验不符合比例风险(PH)假设时,基于常数风险比的网络荟萃分析(NMA)可能会得出有偏的结果。我们旨在总结已发表的时间事件结局非 PH NMA 方法,展示其应用,并比较其结果。
通过肿瘤学中 4 项随机对照试验的无进展生存期和总生存期的实例研究,比较了以下非 PH NMA 方法:(1)基于传统生存分布或分数多项式的 1 步或 2 步多变量 NMA;(2)用于基线风险的受限立方样条 NMA;(3)受限平均生存 NMA。
对于无进展生存期,试验间不满足 PH 假设,而非 PH NMA 方法更好地反映了随时间变化的相对治疗效果。最灵活的模型(分数多项式和受限立方样条)比其他方法更能拟合数据。使用不同非 PH NMA 方法估计的风险比在 5 年随访时相似,但在推断中存在差异。尽管总生存期没有明显的 PH 违反证据,但非 PH NMA 方法捕捉到了随时间变化的相对治疗效果中的这种不确定性。
当部分随机对照试验中 PH 假设存在疑问时,我们建议评估替代的非 PH NMA 方法来估计时间事件结局的相对治疗效果。我们提出了一种透明和明确的逐步模型选择过程,考虑了模型拟合、外部约束和临床有效性。鉴于存在固有不确定性,建议进行敏感性分析。